tradingkey.logo

PureTech Founded Vedanta Biosciences Announces Phase 2 Study Of Ve202 Did Not Meet Primary Endpoint

ReutersAug 13, 2025 4:32 PM

- PureTech Health PLC PRTC.L:

  • PURETECH FOUNDED ENTITY VEDANTA BIOSCIENCES ANNOUNCES PHASE 2 STUDY OF VE202 IN ULCERATIVE COLITIS DID NOT MEET PRIMARY ENDPOINT

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI